Indoco Remedies Limited — Quarter and year ended 31 March 2026 (Standalone and Consolidated)
Indoco Remedies Limited — STATEMENT OF STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31ST MARCH 2026 (Rs. In Lakhs)
| S.No | Particulars | Quarter ended 31.03.2026 (Audited) | Quarter ended 31.12.2025 (Unaudited) | Quarter ended 31.03.2025 (Audited) | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income from Operations | |||||
| (a) Revenue from Operations | 42,906 | 38,957 | 34,107 | 1,63,354 | 1,49,478 | |
| (b) Other Operating Income | 2,007 | 1,094 | 618 | 5,253 | 2,341 | |
| Total Income from Operations (Net) (a+b) | 44,913 | 40,051 | 34,725 | 1,68,607 | 1,51,819 | |
| 2 | Other Income | 1,035 | 717 | 650 | 2,964 | 1,848 |
| 3 | Total Income (1+2) | 45,948 | 40,768 | 35,375 | 1,71,571 | 1,53,667 |
| 4 | Expenses | |||||
| (a) Cost of materials consumed | 9,825 | 8,119 | 7,222 | 35,323 | 33,479 | |
| (b) Purchases of stock-in-trade | 2,908 | 3,299 | 3,062 | 14,012 | 14,093 | |
| (c) Changes in inventories of finished goods, work-in-progress and stock-in-trade | 1,058 | (159) | (1,298) | 720 | (3,204) | |
| (d) Employee Benefits expense | 10,098 | 9,881 | 9,994 | 39,363 | 36,874 | |
| (e) Research & Development Expense | 1,776 | 1,831 | 1,739 | 7,954 | 7,601 | |
| (f) Other Expenses | 12,945 | 14,490 | 13,660 | 55,520 | 50,172 | |
| (g) Finance Costs | 2,273 | 2,015 | 1,598 | 8,850 | 5,663 | |
| (h) Depreciation and Amortization expense | 2,671 | 2,736 | 2,488 | 10,690 | 9,825 | |
| Total Expenses | 43,554 | 42,212 | 38,465 | 1,72,432 | 1,54,503 | |
| 5 | Profit / (Loss) Before Exceptional Items and Tax (3-4) | 2,394 | (1,444) | (3,090) | (861) | (836) |
| 6 | Exceptional Items (*) | 368 | (601) | – | (286) | 99 |
| 7 | Profit Before Tax (5+6) | 2,762 | (2,045) | (3,090) | (1,147) | (737) |
| 8 | Tax Expenses | |||||
| – Current | 292 | – | (293) | 292 | 0 | |
| – Deferred | (265) | (45) | (173) | (873) | 136 | |
| – MAT Credit Adjustments | – | – | – | – | – | |
| Total Tax Expenses | 27 | (45) | – | (581) | 136 | |
| 9 | Profit for the period (7-8) | 2,735 | (2,000) | (2,624) | (566) | (873) |
| 10 | Other Comprehensive Income | |||||
| a) i) Items that will not be reclassified to profit and loss | 403 | (75) | (510) | 178 | (600) | |
| a) ii) Income tax on relating to this item | (102) | 19 | 128 | (45) | 151 | |
| b) i) Items that may be reclassified to profit or loss | (335) | 54 | – | – | – | |
| b) ii) Income tax on relating to this item | 84 | (13) | – | – | – | |
| Total Other Comprehensive Income | 50 | (15) | (382) | 133 | (449) | |
| 11 | Total Comprehensive income for the year (9+10) | 2,785 | (2,015) | (3,006) | (433) | (1,322) |
| 12 | Paid up Equity Share Capital (Face value Rs. 2/- each) | 1,846 | 1,845 | 1,845 | 1,846 | 1,845 |
| 13 | Other Equity | 1,08,073 | 1,08,491 | |||
| 14 | Earnings per share (of Rs. 2/- each) | |||||
| (a) Basic – in Rs. | 2.96 | (2.17) | (2.85) | (0.61) | (0.95) | |
| (b) Diluted – in Rs. | 2.96 | (2.17) | (2.84) | (0.61) | (0.95) |
Indoco Remedies Limited — 10 Statement of Assets and Liabilities (Rs. In Lakhs)
| Sr. No | Particulars | As at 31.03.2026 | As at 31.03.2025 |
|---|---|---|---|
| A ASSETS | |||
| 1 | Non-Current Assets | ||
| (a) Property, Plant and Equipment | 70,346 | 64,114 | |
| (b) Capital Work in Progress | 2,349 | 18,137 | |
| (c) Intangible Assets | 8,008 | 8,376 | |
| (d) Intangible Assets under Development | 6,172 | 4,441 | |
| (e) Right to Use of Asset | 6,791 | 2,948 | |
| (f) Financial Assets | |||
| (i) Investments | 15,975 | 5,196 | |
| (ii) Loans | 5,056 | 13,685 | |
| (iii) Other Financial Assets | 786 | 595 | |
| (g) Other Non-Current Assets | 9,555 | 8,736 | |
| Total – Non-Current Assets | 1,25,138 | 1,26,228 | |
| 2 | Current Assets | ||
| (a) Inventories | 32,183 | 36,287 | |
| (b) Financial Assets | |||
| (i) Investments | – | – | |
| (ii) Trade Receivables | 54,120 | 37,405 | |
| (iii) Cash and Cash Equivalents | 1,294 | 706 | |
| (iv) Bank Balances Other Than (iii) above | 706 | 497 | |
| (v) Loans | 456 | 329 | |
| (vi) Other Financial Assets | 3,559 | 3,242 | |
| (c) Current Tax Assets (Net) | 2,136 | 1,834 | |
| (d) Other Current Assets | 14,577 | 13,588 | |
| (e) Assets Classified as held for Sale | 2,341 | – | |
| Total – Current Assets | 1,11,372 | 93,888 | |
| Total – Assets | 2,36,510 | 2,20,116 | |
| B Equity and Liabilities | |||
| 1 | Equity | ||
| (a) Equity Share Capital | 1,846 | 1,845 | |
| (b) Other Equity | 1,08,073 | 1,08,491 | |
| (c) Non-Controlling Interest | |||
| Total Equity | 1,09,919 | 1,10,336 | |
| 2 | Liabilities | ||
| a) | Non-Current Liabilities | ||
| (a) Financial Liabilities | |||
| (i) Borrowings | 30,161 | 33,689 | |
| (ia) Lease Liabilities | 4,234 | 936 | |
| (ii) Other Financial Liabilities | 275 | 439 | |
| (b) Provisions | 3,468 | 3,489 | |
| (c) Deferred Tax Liabilities (Net) | 157 | 985 | |
| (d) Other Non-Current Liabilities | 749 | 741 | |
| Total – Non-Current Liabilities | 39,044 | 40,279 | |
| b) | Current Liabilities | ||
| (a) Financial Liabilities | |||
| (i) Borrowings | 40,399 | 40,110 | |
| (ia) Lease Liabilities | 1,156 | 617 | |
| (ii) Trade Payables | |||
| (A) Total Outstanding Dues of Micro Enterprises and Small Enterprises | 8,184 | 2,774 | |
| (B) Total Outstanding Dues of Other than Micro Enterprises and Small Enterprises | 17,871 | 11,964 | |
| (iii) Other Financial Liabilities | 9,629 | 7,305 | |
| (b) Provisions | 4,641 | 4,507 | |
| (c) Other Current Liabilities | 5,667 | 2,224 | |
| Total – Current Liabilities | 87,547 | 69,501 | |
| Total Liabilities | 1,26,591 | 1,09,780 | |
| Total – Equity and Liabilities | 2,36,510 | 2,20,116 |
Indoco Remedies Limited — 11 Cash Flow Statement (Rs. In Lakhs)
| Sr. No | Particulars | Year ended 31.03.2026 (Rs. In Lakhs) | Year ended 31.03.2025 (Rs. In Lakhs) |
|---|---|---|---|
| (A) | Cash Flow from Operating Activities: | ||
| Net Profit / (Loss) before tax and extraordinary item | (859) | (837) | |
| Adjustments for: | |||
| Depreciation, Amortisation and Impairment Expense | 10,690 | 9,825 | |
| Gain on sale/disposal of property, plant and equipment | (6) | (24) | |
| Profit on maturity of Investments | – | (66) | |
| Loss on sale/disposal of property, plant and equipment | 66 | 74 | |
| Share based payments to Employees | 60 | 187 | |
| Sundry Balance written back | (2) | (77) | |
| Provision for Doubtful Debts / Bad Debts | 1,315 | 159 | |
| Interest Income | (1,768) | (1,159) | |
| Dividend received on Investments | (0) | (0) | |
| Unrealized Foreign Exchange (Gain) / Loss | (924) | 139 | |
| Finance Cost (Other than Unrealized Foreign Exchange (Gain) / Loss) | 8,850 | 5,664 | |
| Operating Profit before Working Capital Change | 18,281 | 14,722 | |
| Adjustments for: | |||
| Decrease / (Increase) in Trade Receivables | (17,107) | 3,099 | |
| Decrease / (Increase) in Other Current Financial Assets | (444) | (1,942) | |
| Decrease / (Increase) in Other Current Assets | (981) | (1,259) | |
| Decrease / (Increase) in Inventories | 4,103 | (5,245) | |
| Decrease / (Increase) in Other Non Current Financial Assets | (152) | 1 | |
| Decrease / (Increase) in Other Non Current Assets | (1,553) | (8) | |
| Increase / (Decrease) in Trade Payables | 11,319 | 2,918 | |
| Increase / (Decrease) in Non Current Financial Liabilities | (164) | (50) | |
| Increase / (Decrease) in Non Current Provisions | 157 | (458) | |
| Increase / (Decrease) in Lease Liabilities | 4,932 | 397 | |
| Increase / (Decrease) in Other Non Current Liabilities | 8 | 5 | |
| Increase / (Decrease) in Current Financial Liabilities | 2,396 | (1,230) | |
| Increase / (Decrease) in Current Provisions | 135 | (321) | |
| Increase / (Decrease) in Other Current Liabilities | 3,443 | 845 | |
| 17,422 | 13,885 | ||
| 6,092 | (3,248) | ||
| Cash generated from Operations | 23,514 | 10,637 | |
| Income Tax Paid (Net of Refund) | (593) | (1,660) | |
| Net Cash generated from Operating Activities Before Exceptional Items….(A)… | 22,921 | 8,977 | |
| Exceptional items | |||
| Exceptional items | (286) | 99 | |
| Net cash from / (used in) Operating Activities (A) | 22,635 | 9,076 | |
| (B) | Cash Flow from Investing Activities | ||
| Purchase of property, plant and equipment (refer note no. 4 & 5 below) | (12,535) | (25,843) | |
| Proceeds from sale of property, plant and equipment | 4,426 | 355 | |
| Investment in Subsidiaries | (10,779) | (2,890) | |
| Loan given to Subsidiaries | (680) | – | |
| Proceeds from Loan given to Subsidiaries | 9,270 | – | |
| Proceeds from sale of Investments | – | 790 | |
| (Increase)/Decrease in Bank Balance not considered as Cash & Cash Equivalents | (209) | 450 | |
| Interest Received | 1,769 | 1,159 | |
| Dividend received on Investments | – | 0 | |
| Net cash from/ (used in) Investing Activities (B) | (8,738) | (25,979) | |
| (C) | Cash Flow from Financing Activities | ||
| Finance Cost (Other than Unrealized Foreign Exchange (Gain) / Loss) | (8,914) | (5,498) | |
| Payment of Lease Liability | (1,096) | (523) | |
| Proceed from Issue of Equity Shares (ESOPs) | 130 | 159 | |
| Dividend Paid | (191) | (1,390) | |
| Proceeds from Long Term Borrowings | 5,300 | 20,099 | |
| Repayment of Long Term Borrowings | (6,817) | (4,191) | |
| Proceeds / (Repayment) from Short Term Borrowings | (1,721) | 8,206 | |
| Net cash from/ (used in) Financing Activities (C) | (13,309) | 16,862 | |
| Net Increase / (Decrease) in Cash or Cash Equivalents (A+B+C) | 588 | (41) | |
| Cash and Cash Equivalents at the beginning of the Period | 706 | 747 | |
| Cash and Cash Equivalents at the end of the Period | 1,294 | 706 |
Indoco Remedies Limited — STATEMENT OF CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31ST MARCH, 2026 (Rs. In Lakhs)
| S.No | Particulars | Quarter ended 31.03.2026 (Audited) | Quarter ended 31.12.2025 (Unaudited) | Quarter ended 31.03.2025 (Audited) | Year ended 31.03.2026 (Audited) | Year ended 31.03.2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income from Operations | |||||
| (a) Revenue from Operations | 45,590 | 43,434 | 38,389 | 1,79,294 |